Neurocrine Biosciences (NBIX)

Neurocrine Biosciences

NBIX

#1497

Rank

£10.85 B

Marketcap

🇺🇸 United States

Country

£106.80

Share price

-1.55%

Change (1 day)

4.48%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year	Total assets	Change
2025-12-31	£3.43 B	16.06%
2024-12-31	£2.96 B	16.11%
2023-12-31	£2.55 B	30.35%
2022-12-31	£1.95 B	27.52%
2021-12-31	£1.53 B	20.64%
2020-12-31	£1.27 B	27.78%
2019-12-31	£0.99 B	27.29%
2018-12-31	£0.78 B	29.33%
2017-12-31	£0.60 B	104.46%
2016-12-31	£0.29 B	-7.65%
2015-12-31	£0.32 B	105.24%
2014-12-31	£0.15 B	66.47%
2013-12-31	£93.77 M	-22.66%
2012-12-31	£0.12 B	36.2%
2011-12-31	£89.02 M	-4.85%
2010-12-31	£93.55 M	113.78%
2009-12-31	£43.76 M	-45.73%
2008-12-31	£80.63 M	-42.1%
2007-12-31	£0.13 B	-30%
2006-12-31	£0.19 B	-28.99%
2005-12-31	£0.28 B	3.59%
2004-12-31	£0.27 B	-12.82%
2003-12-31	£0.31 B	86.63%
2002-12-31	£0.16 B	-30.41%
2001-12-31	£0.23 B

Total Assets for similar companies or competitors

Company	Total assets	differencediff.	Country
Pfizer PFE	£152.08 B	3,653.07%	🇺🇸 USA
AbbVie ABBV	£102.16 B	2,421.23%	🇺🇸 USA
Eli Lilly LLY	£107.58 B	2,554.98%	🇺🇸 USA
Repligen RGEN	£2.23 B	-44.95%	🇺🇸 USA
Athersys ATHX	£5.61 M	-99.86%	🇺🇸 USA
ANI Pharmaceuticals ANIP	£1.12 B	-72.12%	🇺🇸 USA
Palatin Technologies PTN	£10 M	-99.75%	🇺🇸 USA
Royalty Pharma RPRX	£14.98 B	269.83%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of June 2026 : £4.05 Billion